These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17475613)

  • 1. Concurrent papillary thyroid cancer with pituitary ACTH-secreting tumor.
    Kuo SF; Chen JY; Chuang WY; Jung SM; Chang YC; Lin JD
    J Formos Med Assoc; 2007 Apr; 106(4):330-5. PubMed ID: 17475613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined acromegaly and subclinical Cushing disease related to high-molecular-weight adrenocorticotropic hormone.
    Oki K; Yamane K; Oda Y; Kamei N; Watanabe H; Tominaga A; Amatya VJ; Oki Y; Kohno N
    J Neurosurg; 2009 Feb; 110(2):369-73. PubMed ID: 18991502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
    Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
    Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.
    Luster M; Lassmann M; Haenscheid H; Michalowski U; Incerti C; Reiners C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3640-5. PubMed ID: 11061516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular thyroid carcinoma with metastases to the pituitary causing pituitary insufficiency.
    Vianello F; Mazzarotto R; Taccaliti A; Lora O; Basso M; Servodio O; Mian C; Sotti G
    Thyroid; 2011 Aug; 21(8):921-5. PubMed ID: 21595558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioactive iodine administered for thyroid remnant ablation following recombinant human thyroid stimulating hormone preparation also has an important adjuvant therapy function.
    Tuttle RM; Lopez N; Leboeuf R; Minkowitz SM; Grewal R; Brokhin M; Omry G; Larson S
    Thyroid; 2010 Mar; 20(3):257-63. PubMed ID: 20187781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation.
    Vianello F; Mazzarotto R; Mian C; Lora O; Saladini G; Servodio O; Basso M; Pennelli G; Pelizzo MR; Sotti G
    Clin Oncol (R Coll Radiol); 2012 Apr; 24(3):162-8. PubMed ID: 21411300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell lymphoblastic lymphoma/leukemia within an adrenocorticotropic hormone and thyroid stimulating hormone positive pituitary adenoma: A cytohistological correlation emphasizing importance of intra-operative squash smear.
    Gupta RK; Saran RK; Srivastava AK; Jagetia A; Garg L; Sharma MC
    Neuropathology; 2017 Aug; 37(4):358-364. PubMed ID: 28295636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid cancer in pregnant women: diagnostic and therapeutic management.
    Choe W; McDougall IR
    Thyroid; 1994; 4(4):433-5. PubMed ID: 7711507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ; Erickson D; Castro MR; Atkinson JL
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary carcinoma: a review of the literature.
    Ragel BT; Couldwell WT
    Neurosurg Focus; 2004 Apr; 16(4):E7. PubMed ID: 15191336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual association between a thyrotropin-secreting pituitary adenoma and a papillary thyroid carcinoma.
    Gasparoni P; Rubello D; Persani L; Beck-Peccoz P
    Thyroid; 1998 Feb; 8(2):181-3. PubMed ID: 9510128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
    Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the incidence of differentiated thyroid cancer increased in patients with thyrotropin-secreting adenomas? Report of three cases from a large consecutive series.
    Perticone F; Pigliaru F; Mariotti S; Deiana L; Furlani L; Mortini P; Losa M
    Thyroid; 2015 Apr; 25(4):417-24. PubMed ID: 25647054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pituitary atypical adenoma or malignant corticotrophinoma?].
    Alves M; Paiva I; Belo F; Rebelo O; Bastos M; Carvalheiro M
    Acta Med Port; 2011 Dec; 24 Suppl 3():661-6. PubMed ID: 22856408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH-secreting medullary carcinoma of the thyroid presenting a severe idiopathic osteoporosis and senile purpura: report of a case and review of the literature.
    Rosenberg EM; Hahn TJ; Orth DN; Deftos LJ; Tanaka K
    J Clin Endocrinol Metab; 1978 Aug; 47(2):255-62. PubMed ID: 233664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM; Fleisher M; Francis GL; Robbins RJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine carcinoma of the thyroid causing adrenocorticotrophic hormone-dependent Cushing's syndrome.
    Dutta D; Mukhopadhyay S; Maisnam I; Ghosh S; Mukhopadhyay P; Chowdhury S
    Thyroid; 2013 Jan; 23(1):120-3. PubMed ID: 23140512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.